MORGENS WATERFALL VINTIADIS & CO INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 179 filers reported holding HERON THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.5%.

Quarter-by-quarter ownership
MORGENS WATERFALL VINTIADIS & CO INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,175,000
+62.7%
50,000
+28.2%
0.80%
+44.0%
Q3 2019$722,000
-0.4%
39,0000.0%0.55%
+11.0%
Q2 2019$725,000
-23.9%
39,0000.0%0.50%
-26.8%
Q1 2019$953,000
-5.8%
39,0000.0%0.68%
-24.2%
Q4 2018$1,012,000
-18.0%
39,0000.0%0.90%
+11.5%
Q3 2018$1,234,000
-18.5%
39,0000.0%0.81%
-24.8%
Q2 2018$1,515,00039,0001.07%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders